| The emerging complexity of gene fusions in cancer F Mertens, B Johansson, T Fioretos, F Mitelman Nature Reviews Cancer 15 (6), 371-381, 2015 | 775 | 2015 |
| Cytogenetic and molecular genetic evolution of chronic myeloid leukemia B Johansson, T Fioretos, F Mitelman Acta haematologica 107 (2), 76-94, 2002 | 604 | 2002 |
| The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias AK Andersson, J Ma, J Wang, X Chen, AL Gedman, J Dang, J Nakitandwe, ... Nature genetics 47 (4), 330-337, 2015 | 572 | 2015 |
| Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia H Lilljebjörn, R Henningsson, A Hyrenius-Wittsten, L Olsson, ... Nature communications 7 (1), 11790, 2016 | 373 | 2016 |
| Rearrangement of the transcription factor gene CHOP in myxoid liposarcomas with t(12;16)(q13;p11) P Åman, D Ron, N Mandahl, T Fioretos, S Heim, K Arheden, H Willén, ... Genes, chromosomes and cancer 5 (4), 278-285, 1992 | 373 | 1992 |
| Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases JF Li, YT Dai, H Lilljebjörn, SH Shen, BW Cui, L Bai, YF Liu, MX Qian, ... Proceedings of the National Academy of Sciences 115 (50), E11711-E11720, 2018 | 329 | 2018 |
| Fusion of the MORF and CBP genes in acute myeloid leukemia with the t(10;16)(q22;p13) I Panagopoulos, T Fioretos, M Isaksson, U Samuelsson, R Billström, ... Human molecular genetics 10 (4), 395-404, 2001 | 273 | 2001 |
| Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms B Tesi, J Davidsson, M Voss, E Rahikkala, TD Holmes, SCC Chiang, ... Blood, The Journal of the American Society of Hematology 129 (16), 2266-2279, 2017 | 251 | 2017 |
| The genomic landscape of high hyperdiploid childhood acute lymphoblastic leukemia K Paulsson, H Lilljebjörn, A Biloglav, L Olsson, M Rissler, A Castor, ... Nature genetics 47 (6), 672-676, 2015 | 250 | 2015 |
| Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein M Järås, P Johnels, N Hansen, H Ågerstam, P Tsapogas, M Rissler, ... Proceedings of the National Academy of Sciences 107 (37), 16280-16285, 2010 | 242 | 2010 |
| Microarray-based classification of a consecutive series of 121 childhood acute leukemias: prediction of leukemic and genetic subtype as well as of minimal residual disease status A Andersson, C Ritz, D Lindgren, P Edén, C Lassen, J Heldrup, ... Leukemia 21 (6), 1198-1203, 2007 | 238 | 2007 |
| A field guide for cancer diagnostics using cell‐free DNA: from principles to practice and clinical applications AL Volckmar, H Sültmann, A Riediger, T Fioretos, P Schirmacher, ... Genes, Chromosomes and Cancer 57 (3), 123-139, 2018 | 235 | 2018 |
| Expression Patterns of the Human Sarcoma-Associated GenesFUSandEWSand the Genomic Structure ofFUS P Åman, I Panagopoulos, C Lassen, T Fioretos, M Mencinger, H Toresson, ... Genomics 37 (1), 1-8, 1996 | 213 | 1996 |
| A novel SERPINE1–FOSB fusion gene results in transcriptional up‐regulation of FOSB in pseudomyogenic haemangioendothelioma C Walther, J Tayebwa, H Lilljebjörn, L Magnusson, J Nilsson, ... The Journal of Pathology 232 (5), 534-540, 2014 | 209 | 2014 |
| Diagnosis of acute promyelocytic leukaemia by RT‐PCR: detection of PML‐RARA and RARA‐PML fusion transcripts J Borrow, AD Goddard, B Gibbons, F Katz, D Swirsky, T Fioretos, I Dube, ... British journal of haematology 82 (3), 529-540, 1992 | 189 | 1992 |
| MYC-containing double minutes in hematologic malignancies: evidence in favor of the episome model and exclusion of MYC as the target gene CT Storlazzi, T Fioretos, C Surace, A Lonoce, A Mastrorilli, B Strömbeck, ... Human molecular genetics 15 (6), 933-942, 2006 | 165 | 2006 |
| Fusion of the FUS gene with ERG in acute myeloid leukemia with t(16;21)(p11;q22) I Panagopoulos, P Åman, T Fioretos, M Höglund, B Johansson, ... Genes, Chromosomes and Cancer 11 (4), 256-262, 1994 | 165 | 1994 |
| Molecular characterization of early-stage bladder carcinomas by expression profiles, FGFR3 mutation status, and loss of 9q D Lindgren, F Liedberg, A Andersson, G Chebil, S Gudjonsson, Å Borg, ... Oncogene 25 (18), 2685-2696, 2006 | 164 | 2006 |
| Selective killing of candidate AML stem cells by antibody targeting of IL1RAP M Askmyr, H Ågerstam, N Hansen, S Gordon, A Arvanitakis, M Rissler, ... Blood, The Journal of the American Society of Hematology 121 (18), 3709-3713, 2013 | 163 | 2013 |
| Cellular interactions of CRKL, an SH2–SH3 adaptor protein J ten Hoeve, V Kaartinen, T Fioretos, L Haataja, JW Voncken, ... Cancer research 54 (10), 2563-2567, 1994 | 158 | 1994 |
